NCT02260414View on ClinicalTrials.gov

Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 14, 2015

Primary Completion Date

May 9, 2017

Study Completion Date

May 9, 2017

Conditions
LymphomaMultiple Myeloma
Interventions
DRUG

Tinzaparin

single subcutaneous injection of 4500 IU tinzaparin

OTHER

Blood sample

blood sample taken at hours 0, 3, 8, 18 and 24 after subcutaneous injection of 4500 IU tinzaparin

Trial Locations (1)

42055

CHU de Saint-Etienne, Saint-Etienne

Sponsors

Collaborators (1)

LEO Pharma
All Listed Sponsors
collaborator

LEO Pharma

INDUSTRY

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER